Sign inJoin waitlistJoin the waitlist

Shalin Kothari

, Assistant Professor of Medicine (Hematology), in the Clinician-Educator Track. · Yale-New Haven Hospital

Credentials: · · · · · · ·

History

Medical Oncology and Hematology Fellowship · Yale-New Haven Hospital
Present
Medical Oncology and Hematology Fellowship · Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present

Roswell Park Comprehensive Cancer Center
2016–2019
Internal Medicine
SUNY Upstate Medical University
2013–2016
Gujarat University in India
Gujarat University in India
2007–2011

Research

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era
Journal of Clinical Oncology · 2019 · 79 citations
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics
Blood Advances · 2020 · 41 citations
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia
Blood · 2020 · 33 citations

Pallawi Torka
8 papers · 1 as a fellow
Reem Karmali
8 papers
Scott Huntington
7 papers
David Bond
6 papers · 1 as a fellow
Francisco Hernandez-Ilizaliturri
6 papers
Iris Isufi
6 papers
Jonathon Cohen
6 papers
SB
Stefan Barta
6 papers
Stephanie Halene
6 papers
Adam Olszewski
5 papers
AK
Anna Kress
5 papers
Daniel Landsburg
5 papers

Clinical trials

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2038